SCPS (Scopus BioPharma) Stock Based Compensation: $0.32 Mil (TTM As of Jun. 2023)


What is Scopus BioPharma Stock Based Compensation?

Scopus BioPharma SCPS Stock Based Compensation is $0.32 Mil as of Jun. 2023.

Scopus BioPharma's Stock Based Compensation for the three months ended in Jun. 2023 was $0.08 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 was $0.32 Mil.

Scopus BioPharma Stock Based Compensation Related Terms

Scopus BioPharma Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Scopus BioPharma's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scopus BioPharma Stock Based Compensation Chart

Scopus BioPharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Stock Based Compensation
Get a 7-Day Free Trial 0.01 0.21 0.29 0.67 0.35

Scopus BioPharma Quarterly Data
Jun18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.08 0.08 0.08 0.08

Scopus BioPharma Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.32 Mil.

What does a Stock Based Compensation of $0.32 Mil mean?
Scopus BioPharma (SCPS) has a Stock Based Compensation of $0.32 Mil as of Jun. 2023. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Scopus BioPharma and its competitors.
Is Scopus BioPharma's Stock Based Compensation too high?
Scopus BioPharma's current Stock Based Compensation is $0.32 Mil.
How does Scopus BioPharma's Stock Based Compensation compare to AMPE and DRMA?
Scopus BioPharma's Stock Based Compensation of $0.32 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Scopus BioPharma and its competitors. Scopus BioPharma's current Stock Based Compensation is $0.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scopus BioPharma stock overvalued right now?
Scopus BioPharma (SCPS) has a current Stock Based Compensation of $0.32 Mil. The current Stock Based Compensation is $0.32 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Scopus BioPharma (SCPS), the current Stock Based Compensation is $0.32 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scopus BioPharma Business Description

Address 420 Lexington Avenue, Suite 300, New York, NY, USA, 10170
Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system. The endocannabinoid system is comprised of chemical compounds, or cannabinoids, that interact with cannabinoid receptors which are located throughout the body. Its product candidate comprises CO-sTiRNA, which is a STAT3 inhibitor gene therapy and MRI-1867.